Material Type
Oral Presentation
A Phase 1 Study of KITE-363 Anti-CD19/CD20 Chimeric Antigen receptor (CAR) T-Cell Therapy in Patients with Relapsed/Refractory B-Cell Lymphoma
Author: Dahiya, S
Poster
Real-World Outcomes of Axi-Cel for the Treatment of R/R Secondary Central Nervous System Lymphoma (SCNSL)
Author: Epperla, N
Yescarta
Poster
Trends and Outcomes by Inpatient and Outpatient Infusion of Axi-Cel in the US for Patients with R/R LBCL
Author: Furqan, F
Yescarta